NyquistAI
NyquistAI is an innovative health technology company that provides AI-powered solutions to transform clinical and regulatory data into actionable insights for life sciences professionals. Their products, including Nyquist Pharma, Nyquist MedTech, Nyquist IQ, and Nyquist Scholar, streamline data access and analysis, enabling organizations to enhance their workflows and make informed decisions. With a focus on democratizing knowledge and improving efficiency, NyquistAI serves a diverse range of clients in the life sciences sector, leveraging over 1 billion data points to deliver relevant insights and drive innovation.
NyquistAI
NyquistAI is an innovative health technology company that provides AI-powered solutions to transform clinical and regulatory data into actionable insights for life sciences professionals. Their products, including Nyquist Pharma, Nyquist MedTech, Nyquist IQ, and Nyquist Scholar, streamline data access and analysis, enabling organizations to enhance their workflows and make informed decisions. With a focus on democratizing knowledge and improving efficiency, NyquistAI serves a diverse range of clients in the life sciences sector, leveraging over 1 billion data points to deliver relevant insights and drive innovation.
TL;DR
Sector: Life-sciences AI / health technology
HQ: Palo Alto, CA
Headcount: 13
Latest disclosed funding: Seed, $6.0M (Mar 2022)
Core products: Nyquist IQ, Nyquist Scholar, Nyquist Pharma, Nyquist MedTech
Company Overview
Problem Domain
Making clinical, regulatory, device, and adverse-event data accessible and actionable for life-sciences workflows.
Industry
Health technology; Life sciences software
Funding Track Record
$6,000,000
Round closed March 2022; participant investors include Lightspeed Venture Partners, GSR Ventures, TA Ventures and others.
Investor Signal
“Backed by multiple institutional investors including Peterson Ventures, GSR Ventures, TA Ventures, Lightspeed Venture Partners, Mentors Fund, Village Global, Worm Capital, Catchlight Capital Partners”